Acorda Therapeutics Inc

NASDAQ ACORQ

Data sourced from iex and EODHD
Download Data

Acorda Therapeutics Inc Key Metrics 2023 - 2024

This table shows the Key Metrics for Acorda Therapeutics Inc going from 2023 until 2024. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Accounts Payable Turnover Ratio
R 2.04 2.61 2.25 9.35 7.80
Accounts Receivable Turnover Ratio
R 2.21 2.20 2.31 2.22 2.42
Asset Coverage Ratio
R - - - - -
Asset Turnover Ratio
R 0.48 0.66 0.15 0.16 0.12
Average Collection Period
R 104.66 110.83 114.68 114.01 108.72
Book Value Per Share
R -149.56 -127.17 47.47 54.64 63.24
Capital Expenditure To Sales
% 0.00 0.12 0.00 0.00 0.00
Cash Dividend Coverage Ratio
R - - - - -
Cash Flow Coverage Ratio
R -2.51 -0.33 1.00 -1.49 -0.93
Cash Interest Coverage Ratio
R -2.51 -0.33 1.00 -1.49 -0.93
Cash Per Share
R 7.54 24.14 26.14 20.34 24.86
Cash Ratio
R 0.04 0.13 0.70 0.83 0.87
Cash Return on Assets (CROA)
R -0.25 -0.03 0.02 -0.03 -0.02
Cash Return on Equity (CROE)
R 0.11 0.02 0.13 -0.17 -0.09
Cash Return on Invested Capital (CROIC)
R 0.14 0.03 0.02 -0.03 -0.02
Cash Return on Investment (CROI)
R - - - - -
Cash Taxes
M - - - - -
Cash to Debt Ratio
R - - - - -
Current Assets to Total Assets Ratio
R 0.59 0.69 0.20 0.18 0.18
Current Liabilities Ratio
R 2.75 2.10 0.13 0.08 0.09
Current Liabilities to Total Liabilities Ratio
R 0.84 0.85 0.15 0.10 0.12
Current Ratio
R 0.22 0.33 1.59 2.14 1.96
Days in Inventory
R 815.56 714.78 1,259.77 1,187.65 989.53
Days Inventory Outstanding (DIO)
R 1,390.19 1,053.34 1,933.52 1,762.12 1,519.70
Days Payable Outstanding (DPO)
R 977.93 948.04 1,328.74 378.10 322.11
Days Sales Outstanding (DSO)
R 165.29 166.22 157.73 164.70 150.70
Debt to Asset Ratio
R - - - - -
Debt to Capital Ratio
R - - - - -
Debt to EBITDA Ratio
R - - - - -
Debt to Equity Ratio
R - - - - -
Debt to Income Ratio
R - - - - -
Debt to Tangible Net Worth Ratio
R - - - - -
Dividend Coverage Ratio
R - - - - -
Dividend Payout Ratio
% - - - - -
Dividend Per Share
R - - - - -
EBIT to Fixed Assets Ratio
R - - - - -
EBIT to Total Assets Ratio
R - - - - -
EBITDA Coverage Ratio
R - - - - -
EBITDA Per Share
R - - - - -
Equity Multiplier
R -0.44 -0.69 6.21 5.37 4.87
Equity to Assets Ratio
R -2.28 -1.46 0.16 0.19 0.21
Free Cash Flow Margin
R -0.99 -0.08 0.27 -0.39 -0.32
Free Cash Flow Per Share
R -16.25 -2.47 5.95 -9.30 -5.77
Free Cash Flow to Equity (FCFE)
M - - - - -
Free Cash Flow to Firm (FCFF)
M - - - - -
Gross Profit Per Share
R 13.35 26.07 19.59 21.42 15.63
Gross Profit to Fixed Assets Ratio
R 2.84 5.14 3.63 3.84 2.57
Gross Profit to Tangible Assets Ratio
R - 0.38 - - -
Gross Working Capital
M - - - - -
Interest Coverage Ratio
R - - - - -
Interest Expense To Sales
% 39.71 24.22 27.56 26.19 34.01
Inventory Turnover Ratio
R 0.26 0.35 0.19 0.21 0.24
Invested Capital
M - - - - -
Liabilities to Equity Ratio
R -1.44 -1.69 5.21 4.37 3.87
Long-Term Debt to Equity Ratio
R - - 3.07 2.60 2.23
Long-Term Debt to Total Assets Ratio
R - - 0.49 0.48 0.46
Net Current Asset Value
R -218,893,000.00 -191,687,000.00 -233,659,000.00 -231,914,000.00 -229,852,000.00
Net Debt to EBITDA Ratio
R - - - - -
Net Income Before Taxes
R - - - - -
Net Operating Profit After Tax (NOPAT)
R - - - - -
Net Working Capital to Total Assets Ratio
R -2.15 -1.41 0.07 0.09 0.09
Non-current Assets to Total Assets Ratio
R 0.41 0.31 0.80 0.82 0.82
Non-current Liabilities to Total Liabilities Ratio
R 0.16 0.15 0.85 0.90 0.88
Operating Cash Flow Per Share
R -16.25 -2.43 6.13 -9.30 -5.77
Operating Cash Flow To Current Liabilities
R -0.09 -0.01 0.16 -0.38 -0.20
Operating Cash Flow to Debt Ratio
R - - - - -
Operating Cash Flow to Sales Ratio
% -99.49 -7.95 27.45 -38.94 -31.53
Operating Expense Ratio
% 147.71 81.36 115.64 104.69 141.93
Operating Income Per Share
R -10.78 1.19 -6.22 -3.59 -10.33
Operating Income to Total Debt
R - - - - -
Payables Turnover
R 0.37 0.39 0.27 0.97 1.13
Pre-Tax Margin
% - - - - -
Quick Ratio
R 0.15 0.26 1.21 1.65 1.57
Research and Development (R&D) Expense Ratio
% 4.70 2.66 4.36 5.22 6.23
Retained Earnings To Equity Ratio
R 6.55 7.53 -16.48 -14.18 -12.38
Retention Ratio
% - - - - -
Return on Assets (ROA)
% -33.58 -200.66 -2.43 -2.57 -4.49
Return on Capital Employed (ROCE)
% - - - - -
Return on Common Equity
% - - - - -
Return on Equity (ROE)
% 14.75 137.86 -15.08 -13.82 -21.86
Return on Fixed Assets (ROFA)
% -469.57 -3,456.52 -132.54 -135.41 -226.98
Return on Gross Investment (ROGI)
% - - - - -
Return on Investment (ROI)
% - - - - -
Return on Net Assets (RONA)
% 29.17 489.86 -2.26 -2.35 -4.12
Return on Net Investment (RONI)
% - - - - -
Return on Sales (ROS)
% -135.02 -573.28 -32.07 -31.61 -75.59
Return on Tangible Equity (ROTE)
% - - - - -
Return on Total Capital (ROTC)
% - - - - -
Revenue Per Share
M 0 0 0 0 0
Sales to Fixed Assets Ratio
R 3.48 6.03 4.13 4.28 3.00
Sales to Operating Cash Flow Ratio
R -1.01 -12.59 3.64 -2.57 -3.17
Sales to Total Assets Ratio
R 0.25 0.35 0.08 0.08 0.06
Sales to Working Capital Ratio
R -0.12 -0.25 1.01 0.86 0.67
Selling, General, and Administrative (SG&A) Expense Ratio
% 139.83 58.46 83.54 73.55 101.15
Short-Term Debt to Equity Ratio
R - - - - -
Short-Term Debt to Total Assets Ratio
R - - - - -
Tangible Asset Value Ratio
R - - - - -
Tangible Book Value per Share
R - - - - -
Total Debt to Capital Ratio
R - - - - -
Total Liabilities to Total Assets Ratio
R 3.28 2.46 0.84 0.81 0.79
Working Capital to Current Liabilities Ratio
R -0.78 -0.67 0.59 1.14 0.96
Working Capital To Sales Ratio
R -8.65 -4.03 0.99 1.16 1.50
Working Capital Turnover Ratio
R -0.12 -0.25 1.01 0.86 0.67

StockViz Staff

September 16, 2024

Any question? Send us an email